Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
11 |
Material Type: Artigo
|
Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphomaRizzieri, David A. ; Johnson, Jeffrey L. ; Niedzwiecki, Donna ; Lee, Edward J. ; Vardiman, James W. ; Powell, Bayard L. ; Barcos, Maurice ; Bloomfield, Clara D. ; Schiffer, Charles A. ; Peterson, Bruce A. ; Canellos, George P. ; Larson, Richard A.Cancer, 2004-04, Vol.100 (7), p.1438-1448 [Periódico revisado por pares]Hoboken: Wiley Subscription Services, Inc., A Wiley CompanyTexto completo disponível |
|
12 |
Material Type: Artigo
|
Chemoimmunotherapy with hyper‐CVAD plus rituximab for the treatment of adult Burkitt and Burkitt‐type lymphoma or acute lymphoblastic leukemiaThomas, Deborah A. ; Faderl, Stefan ; O'Brien, Susan ; Bueso‐Ramos, Carlos ; Cortes, Jorge ; Garcia‐Manero, Guillermo ; Giles, Francis J. ; Verstovsek, Srdan ; Wierda, William G. ; Pierce, Sherry A. ; Shan, Jianqin ; Brandt, Mark ; Hagemeister, Fredrick B. ; Keating, Michael J. ; Cabanillas, Fernando ; Kantarjian, HagopCancer, 2006-04, Vol.106 (7), p.1569-1580 [Periódico revisado por pares]Hoboken: Wiley Subscription Services, Inc., A Wiley CompanyTexto completo disponível |
|
13 |
Material Type: Artigo
|
A phase 2 study with a daily regimen of the oral mTOR inhibitor RAD001 (everolimus) in patients with metastatic clear cell renal cell cancerAmato, Robert J. ; Jac, Jaroslaw ; Giessinger, Sarah ; Saxena, Somyata ; Willis, James P.Cancer, 2009-06, Vol.115 (11), p.2438-2446 [Periódico revisado por pares]Hoboken: Wiley Subscription Services, Inc., A Wiley CompanyTexto completo disponível |
|
14 |
Material Type: Artigo
|
Results of a 2‐arm, phase 2 clinical trial using post‐transplantation cyclophosphamide for the prevention of graft‐versus‐host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantationGaballa, Sameh ; Ge, Isabell ; El Fakih, Riad ; Brammer, Jonathan E. ; Kongtim, Piyanuch ; Tomuleasa, Ciprian ; Wang, Sa A. ; Lee, Dean ; Petropoulos, Demetrios ; Cao, Kai ; Rondon, Gabriela ; Chen, Julianne ; Hammerstrom, Aimee ; Lombardi, Lindsey ; Alatrash, Gheath ; Korbling, Martin ; Oran, Betul ; Kebriaei, Partow ; Ahmed, Sairah ; Shah, Nina ; Rezvani, Katayoun ; Marin, David ; Bashir, Qaiser ; Alousi, Amin ; Nieto, Yago ; Qazilbash, Muzaffar ; Hosing, Chitra ; Popat, Uday ; Shpall, Elizabeth J. ; Khouri, Issa ; Champlin, Richard E. ; Ciurea, Stefan O.Cancer, 2016-11, Vol.122 (21), p.3316-3326 [Periódico revisado por pares]United StatesTexto completo disponível |
|
15 |
Material Type: Artigo
|
Blastic plasmacytoid dendritic cell neoplasm (BPDCN): A promising future in the era of targeted therapeuticsAdimora, Ijele J. ; Wilson, Nathaniel R. ; Pemmaraju, NaveenCancer, 2022-08, Vol.128 (16), p.3019-3026 [Periódico revisado por pares]Atlanta: Wiley Subscription Services, IncTexto completo disponível |
|
16 |
Material Type: Artigo
|
Results of second salvage therapy in 673 adults with acute myelogenous leukemia treated at a single institution since 2000Kantarjian, Hagop M. ; DiNardo, Courtney D. ; Nogueras‐Gonzalez, Graciela M. ; Kadia, Tapan M. ; Jabbour, Elias ; Bueso‐Ramos, Carlos E. ; O'Brien, Susan M. ; Konopleva, Marina ; Jain, Nitin B. ; Daver, Naval G. ; Shpall, Elizabeth J. ; Champlin, Richard E. ; Simkins, Aron ; Garcia‐Manero, Guillermo ; Keating, Michael J. ; Huang, Xuelin ; Cortes, Jorge E. ; Pierce, Sherry A. ; Ravandi, Farhad ; Freireich, Emil J.Cancer, 2018-06, Vol.124 (12), p.2534-2540 [Periódico revisado por pares]United States: Wiley Subscription Services, IncTexto completo disponível |
|
17 |
Material Type: Artigo
|
A randomized phase 2 study of idarubicin and cytarabine with clofarabine or fludarabine in patients with newly diagnosed acute myeloid leukemiaJabbour, Elias ; Short, Nicholas J. ; Ravandi, Farhad ; Huang, Xuelin ; Xiao, Lianchun ; Garcia‐Manero, Guillermo ; Plunkett, William ; Gandhi, Varsha ; Sasaki, Koji ; Pemmaraju, Naveen ; Daver, Naval G. ; Borthakur, Gautam ; Jain, Nitin ; Konopleva, Marina ; Estrov, Zeev ; Kadia, Tapan M. ; Wierda, William G. ; DiNardo, Courtney D. ; Brandt, Mark ; O'Brien, Susan M. ; Cortes, Jorge E. ; Kantarjian, HagopCancer, 2017-11, Vol.123 (22), p.4430-4439 [Periódico revisado por pares]United States: Wiley Subscription Services, IncTexto completo disponível |
|
18 |
Material Type: Artigo
|
Phase 1/2 study of DFP‐10917 administered by continuous intravenous infusion in patients with recurrent or refractory acute myeloid leukemiaKantarjian, Hagop M. ; Jabbour, Elias J. ; Garcia‐Manero, Guillermo ; Kadia, Tapan M. ; DiNardo, Courtney D. ; Daver, Naval G. ; Borthakur, Gautam ; Jain, Nitin ; Waukau, Jane B. ; Kwari, Monica I. ; Ravandi, Farhad ; Anderson, Barry D. ; Iizuka, Kenzo ; Jin, Cheng ; Zhang, Chun ; Plunkett, William K.Cancer, 2019-05, Vol.125 (10), p.1665-1673 [Periódico revisado por pares]United States: Wiley Subscription Services, IncTexto completo disponível |
|
19 |
Material Type: Artigo
|
Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome‐related burkitt lymphoma/leukemiaCortes, Jorge ; Thomas, Deborah ; Rios, Adan ; Koller, Charles ; O'Brien, Susan ; Jeha, Sima ; Faderl, Stefan ; Kantarjian, HagopCancer, 2002-03, Vol.94 (5), p.1492-1499 [Periódico revisado por pares]New York: John Wiley & Sons, IncTexto completo disponível |
|
20 |
Material Type: Artigo
|
New agents in acute myeloid leukemia and other myeloid disordersRavandi, Farhad ; Kantarjian, Hagop ; Giles, Francis ; Cortes, JorgeCancer, 2004-02, Vol.100 (3), p.441-454 [Periódico revisado por pares]Hoboken: Wiley Subscription Services, Inc., A Wiley CompanyTexto completo disponível |